-
CBE-04-Brown: Engineering Synthetic Plasmid Nuclear Targeting Sequences for Gene Therapy (Fully Funded EPSRC-AstraZeneca CASE) Department of Chemical & Biological Engineering PhD Research Project
-
assembly. The project will be run in collaboration with industrial partners at AstraZeneca, GSK, Merck and Codexis. Together we will focus on developing next generation enzymatic peptide assembly technology
-
offered full time on a fixed term contract until 27 February 2026 and is funded by AstraZeneca. Only applications received before 12 midday on Thursday 9 May 2024 will be considered. Please quote 171688
-
) to support early-phase clinical trials in the UK and worldwide. We manufactured the first doses of the Oxford AstraZeneca vaccine against Covid-19 for the UK trials and vaccines for Malaria, TB, Zika, Rabies
-
funded by AstraZeneca. Only applications received before 12 midday on Thursday 9 May 2024 will be considered. Please quote 171688 on all correspondence.
-
manufactured the first doses of the Oxford AstraZeneca vaccine against Covid-19 for the UK trials and vaccines for Malaria, TB, Zika, Rabies, Plague, Ebola and other diseases that have a global impact. You will
-
of the Oxford–AstraZeneca vaccine, which is estimated to have saved over 6 million lives. About the role: This fundraiser will work closely with the Heads of Departments and academics in the Departments
-
function using novel CRISPR/Cas9-based knockouts in the zebrafish in partnership with AstraZeneca. We wish to recruit a talented individual to support the research team led by Prof. Charles Tyler based in
-
of the Oxford–AstraZeneca vaccine, which is estimated to have saved over 6 million lives. About the role: This fundraiser will work closely with the Heads of Departments and academics in the Departments
-
(Biochemistry, Bristol) as well as scientists at AstraZeneca in Sweden giving opportunities alongside organic synthesis and biocatalysis to gain further experience of computational methods as well as structural